The National Institutes of Health has awarded $20 million to fund five additional hubs designed to speed up the translation of biomedical discoveries into commercially viable diagnostics, devices, therapeutics, and tools to improve patient care and enhance health. The newly selected Research Evaluation and Commercialization Hubs (REACH) expand a national network of proof-of-concept centers that links 34 academic institutions developing best practices to translate biomedical innovations into public benefit.
Thanks to innovative leadership at CU Anschutz including David Schwartz, MD, David Ross, PhD, Naresh Mandava, MD, and Richard Zane, MD, CU Innovations is bringing SPARK to life as a Chancellor’s initiative at CU Anschutz Medical Campus. SPARK is a program designed to bridge the translational gap in advancing biomedical discoveries into promising new treatments for patients. The initiative gained approval in Fall 2017 and will begin at CU Anschutz in July 2018.